The Financial Times (FT) Global Pharmaceutical and Biotechnology Conference, in association with Deloitte, will explore how the industry can capitalize on significant new opportunities for growth through new models and approaches to R&D, sales and marketing, pricing and regulation.

The FT Global Pharmaceutical and Biotechnology Conference is Europe’s pre-eminent industry event attended by leading executives, government decision makers, investors, analysts and other specialist providers. It provides a unique platform to present new perspectives, ‘feel the pulse’ of the industry, and network with peers across the sector.

Confirmed Speakers:

Mr. David Brennan, Chief Executive Officer, AstraZeneca PLC

Mr. William M. Burns, Chief Executive Officer, Roche Pharmaceutical Division

Mr. Jon Symonds, Managing Director, Goldman Sachs International

Mr. Angus Russell, Chief Executive Officer, Shire Pharmaceuticals Group PLC

Mr. Wayne Gattinella, President and CEO, WebMD

Mr. Said Darwazah, Chief Executive Officer, Hikma Pharmaceuticals PLC

Mr. Joe Jimenez, Chief Executive Officer, Novartis Pharma AG

Mr. Satish Reddy, MD and Chief Operating Office, Dr. Reddy’s

Takashi Shoda, President and CEO, Daiichi Sankyo Limited

Mr. Bob Go, Global Life Sciences and Health Care Industry Leader, Deloitte Touche Tohmatsu

Conference Chair:

Mr. Andrew Jack, Pharmaceutical Correspondent, Financial Times

For a full agenda and to register, please visit www.ftpharmabiotech.com or call Aliki Varsamides: Telephone +44 (0) 20 7873 4109 Quote Ref: FTNPAD.